Cnbx Pharmaceuticals
(OTC) CNBX
Cnbx Pharmaceuticals Financials at a Glance
Market Cap
$87,100
Revenue (TTM)
$0.00
Net Income (TTM)
$393.34K
EPS (TTM)
$-0.00
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$0.00
Volume
12
Open
$0.00
Price
$0.00
Volume
12
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$0.00
Volume
12
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
CNBX News
CNBX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cnbx Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
1
CEO
Eyal Barad, MBA
Website
www.cnbxpharma.comHeadquarters
Bethesda, MD 20814, US
CNBX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
12%
Return on Assets
-35%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$87.10K
Shares Outstanding
870.77M
Volume
12
Short Interest
0.00%
Avg. Volume
16.71M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$271.69K
EBITDA
$273.79K
Operating Cash Flow
$171.31K
Capital Expenditure
$0.00
Free Cash Flow
$171.31K
Cash & ST Invst.
$15.11K
Total Debt
$1.20M
Cnbx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$87.10K
N/A
Market Cap/Employee
$87.10K
N/A
Employees
1
N/A
Net Income
$113.72K
-231.0%
EBITDA
$64.00K
-73.7%
Quarterly Fundamentals
Net Cash
$1.24M
+5.5%
Accounts Receivable
$3.46K
-30.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.25M
-6.2%
Return on Assets
-35.24%
N/A
Return on Invested Capital
11.62%
N/A
Free Cash Flow
$47.41K
-21.3%
Operating Cash Flow
$47.41K
-21.3%